|
1
|
Kolyadina I, Bulavina I, Petkau V, Gorbunova V, Zhukova L, Ganshina I, Ponomarenko D, Shikina V, Popova N, Golberg V. Efficacy of eribulin in patients with metastatic breast cancer with brain metastases in routine practice in Russian Federation. Breast 2019. [DOI: 10.1016/s0960-9776(19)30240-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
|
2
|
Zhukova L, Lubennikova E, Ganshina I, Bekyashev AH, Kobyakova E, Moskvina E, Vetlova E, Zeynalova K. Clinical outcome of Russian HER2-positive breast cancer patients with brain metastases: Retrospective review. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e13025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- L.G. Zhukova
- “N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - E. Lubennikova
- “N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - I. Ganshina
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - A. H. Bekyashev
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - E. Kobyakova
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - E. Moskvina
- “N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
| | - E. Vetlova
- “ N.N. Burdenko National Medical Research Center for Neurosurgery” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - K Zeynalova
- . Oncological Clinic of the Azerbaijan Medical University, Baku, Azerbaijan
| |
Collapse
|
|
3
|
Lubennikova E, Zhukova L, Lichinitser M, Stepanova E, Vishnevskaya Y, Khochenkov D, Ganshina I, Borisova E. ERCC1 and XRCC1 as prognostic biomarkers for early HER2-positive breast cancer. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e12562] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- E. Lubennikova
- “N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - Lyudmila Zhukova
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - Mikhail Lichinitser
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - E. Stepanova
- N.N. Blokhin Russian Cancer Research Center, Moscow, Russia
| | - Y. Vishnevskaya
- N.N.Blokhin Russian Cancer Research Center, Moscow, Russian Federation
| | - D. Khochenkov
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - I. Ganshina
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | - E. Borisova
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, M, Russian Federation
| |
Collapse
|
|
4
|
Kolyadina IV, Ganshina I, Zhukova L, Gordeeva O, Bokhian VY, Komov D, Pavlikova O, Vishnevskaya YV, Poddubnaya I. The effectiveness, safety and economic rationality of the neoadjuvant chemotherapy with biosimilar of Trastuzumab in HER2+ breast cancer in Russian clinical practice. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e12656] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - I. Ganshina
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | | | - Olga Gordeeva
- Russsian Cancer Research Center N.N. Blokhin, Moscow, RU
| | - Vahan Yurikovich Bokhian
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russian Federation
| | - Dmitrii Komov
- Russian Medical Academy for Postgraduate Education Russian Cancer Research Centre, Moscow, Russian Federation
| | - Olga Pavlikova
- Russian Medical Academy for Postgraduate Education Russian Cancer Research Centre, Moscow, Russian Federation
| | - Yana V Vishnevskaya
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
| | - Irina Poddubnaya
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
| |
Collapse
|
|
5
|
Kolyadina IV, Bokhian VY, Pavlikova O, Komov D, Ganshina I, Zhukova L, Lyubchenko L, Kozlov N, Poddubnaya I. Clinical and biological features and response to preoperative chemotherapy in Russian women with breast cancer stage T1-3N0-1 according to genetic status. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.e12651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Vahan Yurikovich Bokhian
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russian Federation
| | - Olga Pavlikova
- Russian Medical Academy for Postgraduate Education Russian Cancer Research Centre, Moscow, Russian Federation
| | - Dmitry Komov
- Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Healf of the Russian Federation, Moscow, Russian Federation
| | - I. Ganshina
- N.N. Blokhin National Medical Cancer Research Center” of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation
| | | | - Liudmila Lyubchenko
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
| | - Nikolay Kozlov
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
| | - Irina Poddubnaya
- N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
| |
Collapse
|
|
6
|
Kolyadina I, Ganshina I, Zhukova L, Abdullaev A, Komov D, Poddubnaya I, Pavlikova O, Vishnevskaya Y, Kozlov N, Khokhlova S. The first results of neoadjuvant therapy with the biosimilar of trastuzumab in HER2+ breast cancer stage II-III in routine Russian practice. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30547-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
|
7
|
|